Contravir Pharmaceuticals, Inc.
Records under this name other than patents Contravir Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Contravir Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,200,038 | Cyclosporine analogue molecules modified at amino acid 1 and 3 Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,714,271 | Cyclosporine analogue molecules modified at amino acid 1 and 3 Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,573,971 | Method of Preparation of Antiviral Compounds and Useful Intermediates Thereof Lapsed on the fee record Ended Feb 21, 2021 · High confidence | Lapsed on the fee record | Ended Feb 21, 2021 | High confidence |
| US 9,260,469 | Method of Preparation of Antiviral Compounds and Useful Intermediates Thereof Lapsed on the fee record Ended Feb 16, 2020 · High confidence | Lapsed on the fee record | Ended Feb 16, 2020 | High confidence |